Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects
Olivier Barret(Invicro (United States)), Danna Jennings, Robert A. Comley(AbbVie (United States)), Gilles Tamagnan(Chapel Haven Schleifer Center), Thomas Morley(Elucid Bioimaging), John Seibyl(Elucid Bioimaging), Robby M. Weimer(Sunesis (United States)), Sandra Sanabria, Caroline Papin(Elucid Bioimaging), Edilio Borroni(Roche (Switzerland)), Mark A. Mintun(Washington University in St. Louis), Nicholas Seneca(Roche (Switzerland)), Kenneth Marek(University of Pennsylvania), David Alagille(Chapel Haven Schleifer Center)
Cited by 77
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
|Journal of Neuroscience|2005|2.1k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus
|Proceedings of the National Academy of Sciences|2010|1.2k